News - 26 Mar `15VRF - VSI collaboration discussed at the AAD annual meeting

New

FAQOther Questions

  • Will it spread?

    Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study, her...

  • Polypodium leucotomos as an adjunct treatment for vitiligo?

    The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...

  • Who is prone to vitiligo?

    Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...